Covid vaccine: Covaxin phase 3 trials on 3,000 people in UP, says minister
Video Credit: HT Digital Content - Duration: 02:29s - Published
Covid vaccine: Covaxin phase 3 trials on 3,000 people in UP, says minister
Hyderabad-based pharma company Bharat Biotech to conduct phase 3 clinical trial tests in October.
Uttar Pradesh Health Minister Jai Pratap Singh said around 3,000 people to be tested under the phase 3 trial of the vaccine candidate.
Bharat Biotech is working with the Indian Council of Medical Research (ICMR) to develop a vaccine candidate – Covaxin.
The pharma company recently signed an agreement with the Washington University School of Medicine for an intranasal single-dose vaccine.
Watch the full video for more details.
![New promising results from Moderna vaccine trial [Video]](https://video.newsserve.net/300/v/20200930/2009301939-New-promising-results-from-Moderna-vaccine-trial.jpg)
![Moderna and Regeneron Jump on Positive Covid-19 Vaccine Trials [Video]](https://video.newsserve.net/300/v/20200930/2009301314-Moderna-and-Regeneron-Jump-on-Positive-Covid-19.jpg)
![Bharat Biotech will involve 3,000 people for phase-III trials of COVID vaccine in UP [Video]](https://video.newsserve.net/300/v/20200930/2009300717-Bharat-Biotech-will-involve-000-people-for.jpg)
